HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jos H Beijnen Selected Research

Overweight

2/2023Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism.
1/2015Gastric bypass may promote weight loss in overweight partners.
3/2012Overweight children with type 1 diabetes have a more favourable lipid profile than overweight non-diabetic children.
9/2011Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
5/2011Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children.
9/2009Identifying the metabolic syndrome in obese children and adolescents: do age and definition matter?
6/2009Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
5/2009The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin.
1/2009Ethnic differences in cardiometabolic risk profile in an overweight/obese paediatric cohort in the Netherlands: a cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jos H Beijnen Research Topics

Disease

242Neoplasms (Cancer)
05/2024 - 01/2002
115Breast Neoplasms (Breast Cancer)
05/2023 - 09/2002
31Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 11/2002
21Prostatic Neoplasms (Prostate Cancer)
02/2024 - 03/2005
18Neutropenia
01/2022 - 05/2002
17Melanoma (Melanoma, Malignant)
05/2024 - 12/2003
16Brain Neoplasms (Brain Tumor)
01/2022 - 07/2003
15Visceral Leishmaniasis (Kala Azar)
05/2024 - 01/2012
14Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 03/2006
14Renal Cell Carcinoma (Grawitz Tumor)
05/2020 - 02/2007
14Neoplasm Metastasis (Metastasis)
01/2020 - 11/2002
12Ovarian Neoplasms (Ovarian Cancer)
05/2023 - 01/2002
10Leishmaniasis
05/2024 - 08/2008
10Nausea
01/2020 - 10/2005
9Overweight
02/2023 - 01/2009
9Sarcoma (Soft Tissue Sarcoma)
05/2020 - 05/2007
9Glioblastoma (Glioblastoma Multiforme)
01/2020 - 05/2007
9Hypertension (High Blood Pressure)
01/2017 - 01/2009
8Body Weight (Weight, Body)
10/2023 - 05/2002
8Glioma (Gliomas)
11/2018 - 12/2009
7Diarrhea
03/2024 - 09/2011
7Vomiting
12/2016 - 10/2005
7Carcinoma (Carcinomatosis)
09/2016 - 10/2003
6Glucose Intolerance
08/2023 - 05/2011
6Dihydropyrimidine Dehydrogenase Deficiency
01/2022 - 01/2012
6Thrombocytopenia (Thrombopenia)
01/2020 - 06/2005
6Exanthema (Rash)
01/2020 - 09/2003
5Obesity
08/2023 - 01/2009
5Pancreatic Neoplasms (Pancreatic Cancer)
05/2023 - 03/2008
5Neglected Diseases
11/2022 - 03/2012
5Hepatocellular Carcinoma (Hepatoma)
01/2020 - 02/2006
5Fatigue
12/2016 - 09/2011
5Dementia (Dementias)
01/2016 - 12/2005
5Infections
12/2011 - 09/2002
5Renal Insufficiency (Renal Failure)
09/2011 - 05/2002

Drug/Important Bio-Agent (IBA)

67Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2002
45Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021 - 04/2004
33Docetaxel (Taxotere)FDA Link
03/2024 - 02/2003
28Biomarkers (Surrogate Marker)IBA
01/2023 - 03/2005
21Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 07/2003
18Carboplatin (JM8)FDA LinkGeneric
01/2023 - 09/2002
18Tyrosine Kinase InhibitorsIBA
06/2020 - 05/2007
15miltefosine (Impavido)IBA
05/2024 - 08/2008
15Capecitabine (Xeloda)FDA Link
05/2020 - 03/2004
15GemcitabineFDA Link
02/2015 - 11/2002
13Ritonavir (Norvir)FDA Link
01/2024 - 11/2002
13Cytochrome P-450 CYP3AIBA
10/2023 - 01/2006
13PlatinumIBA
01/2023 - 05/2002
13EnzymesIBA
01/2022 - 10/2002
13ElacridarIBA
01/2018 - 07/2003
11Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 09/2002
11TamoxifenFDA LinkGeneric
10/2021 - 06/2011
11Cisplatin (Platino)FDA LinkGeneric
02/2021 - 03/2002
11Blood Proteins (Serum Proteins)IBA
10/2012 - 03/2006
10Monoclonal AntibodiesIBA
10/2023 - 08/2009
10Peptides (Polypeptides)IBA
08/2023 - 01/2010
10Phosphotransferases (Kinase)IBA
06/2023 - 08/2010
10Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 01/2006
9DNA (Deoxyribonucleic Acid)IBA
04/2024 - 05/2004
9Adenosine Triphosphate (ATP)IBA
01/2018 - 11/2002
8Imatinib Mesylate (Gleevec)FDA Link
10/2023 - 05/2007
8Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2021 - 08/2008
8pazopanibFDA Link
01/2020 - 01/2012
8TrabectedinIBA
12/2009 - 01/2002
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2024 - 10/2013
7olaparibIBA
05/2023 - 07/2011
7Trastuzumab (Herceptin)FDA Link
02/2016 - 08/2009
7N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
10/2011 - 09/2002
7Topotecan (Hycamtin)FDA LinkGeneric
07/2009 - 01/2002
7Nevirapine (Viramune)FDA Link
07/2005 - 09/2002
6CrizotinibIBA
10/2023 - 03/2014
6ErbB Receptors (EGF Receptor)IBA
10/2022 - 08/2008
6Cetuximab (Erbitux)FDA Link
09/2022 - 02/2010
6Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
08/2022 - 10/2005
6Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022 - 10/2015
6Hormones (Hormone)IBA
01/2022 - 01/2012
6Anaplastic Lymphoma KinaseIBA
01/2021 - 03/2014
6ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2021 - 11/2002
6taxaneIBA
01/2019 - 04/2004
64-hydroxy-N-desmethyltamoxifenIBA
12/2018 - 06/2011
6Sunitinib (Sutent)FDA Link
05/2015 - 01/2012
6imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA
02/2015 - 11/2002
6ATP-Binding Cassette Sub-Family B Member 4IBA
10/2013 - 01/2006
6Glucose (Dextrose)FDA LinkGeneric
01/2013 - 01/2009
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2009 - 09/2002
5osimertinibIBA
06/2023 - 09/2016
5Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2022 - 05/2014
5EverolimusFDA Link
01/2022 - 08/2012
5Taxoids (Taxanes)IBA
04/2021 - 09/2005
5Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2016 - 08/2007
5RutheniumIBA
02/2015 - 11/2002
5Triglycerides (Triacylglycerol)IBA
07/2013 - 05/2009

Therapy/Procedure

62Therapeutics
12/2023 - 11/2002
32Drug Therapy (Chemotherapy)
06/2023 - 09/2002
12Castration
10/2023 - 01/2019
8Oral Administration
10/2023 - 06/2004
8Lasers (Laser)
07/2012 - 12/2003
6Intravenous Administration
03/2024 - 05/2007
6Drug Tapering
10/2019 - 05/2007
5Radiotherapy
11/2018 - 08/2006